September 27, 2021

The World Live Breaking News Coverage & Updates IN ENGLISH

The World Live Breaking News Coverage & Updates IN ENGLISH

Why US is pushing India to restart Covid vaccine exports

2 min read
Why US is pushing India to restart Covid vaccine exports
Share This :
Why US is pushing India to restart Covid vaccine exports
Why US is pushing India to restart Covid vaccine exports

NEW DELHI: The United States has been pushing India to restart vaccine exports as it looks to stem the global spread of the Covid pandemic.
The US is communicating regularly with India in bilateral and multilateral channels to discuss the supply of Covid-19 vaccines and inquire about its timeline for restarting vaccine exports, a senior Biden administration official told Reuters.
The supply of Covid vaccines will also be one of the key topics of discussion during the first in-person Quad leadership meeting in US on September 24.
During their virtual meeting in March this year, the Quad leaders had agreed to work closely on boosting Covid-19 vaccine supply.
However, the initiative was stalled after India was struck by the deadly second wave of the virus.
Since then, India’s vaccine exports took a major hit as the country sought to prioritise immunisation of its population of over 1.3 billion people.
According to Axios, the Biden administration is now looking to push Modi to renew vaccine supply to the world through the global Covax initiative since it wants to mitigate the international spread of the virus.
“Vaccinating as much of the developing world, as quickly as possible, is in America’s vital interest, because the uncontrolled spread of the virus inevitably produces more dangerous variants,” the Axios report said.
The Biden administration said the issue of vaccine exports is being discussed but did not confirm whether it is tied to Modi’s upcoming participation in the Quad summit.
“Washington was staying in close touch with India and other Quad partners about the vaccine partnership, and any factors that may affect this project or global vaccine supply, but those discussions were not tied to a specific summit or engagement,” the US official said.
The official noted that Washington had diverted its own supply of raw materials for vaccine production to India in April, given its urgent needs, and global vaccine supply remained a key bottleneck to ending the pandemic.
“We commend India for being one of the largest manufacturers for safe and effective COVID-19 vaccines globally, and we note that COVAX and the world rely heavily on India’s contributions,” the official said. “It’s important for the United States to engage all our allies and partners on these matters so we can take the necessary actions to end this pandemic together.”
(With inputs from agencies)

Share This :
Copyright © All rights reserved. | Newsphere by AF themes.